NANS 2026 Annual Meeting covers neuromodulation science, applied innovation, real-world clinical discussion — January Las Vegas
Summary
The North American Neuromodulation Society (NANS) 2026 Annual Meeting was held January 22-25 in Las Vegas, gathering top neuromodulation clinicians, researchers, and industry representatives for the premier annual clinical neuromodulation conference. Featured topics included adaptive DBS (Medtronic BrainSense), responsive neurostimulation (NeuroPace), closed-loop SCS (Saluda Medical Evoke), high-frequency SCS (now Globus Medical/Nevro HFX), and emerging indications including psychiatry, obesity, and autonomic disorders. The meeting was highlighted in Neurotech Notables #46 as a key neuromodulation ecosystem gathering.
Why it matters
NANS is the primary forum where neuromodulation evidence becomes clinical practice — where device company data is presented, debated, and ultimately adopted into the implanting neurosurgeon community's practice patterns. The 2026 meeting occurred simultaneously with the largest wave of clinical trial readouts and FDA approvals in neuromodulation history, making it the most consequential NANS in the society's history.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial